After Noah’s mother, swimming.-eye coordination is now very difficult for Noah, and though loves loves baseball and tennis, he instead of instead of swimming read more . She says, Noah never lets his spirits down. .
Pharma Receives Orphan Drug Designation for its botanical drug, Polyphenon E in the treatment of CLLPolyphenon Pharma, an emerging research-based pharmaceutical company, announced that the Food and Drug Administration has grants Orphan Drug Designation to its herbal drug, Polyphenon E , for the treatment of chronic lymphocytic leukemia . A Phase II study is currently at the Mayo Clinic in Rochester, Minnesota, where researchers study the effects of a daily oral dose of Polyphenon E in CLL patients is ongoing. – Represents the FDA Orphan Drug Designation for Polyphenon E represents an important milestone in the development of this drug, said Stig Ogata, Polyphenon Pharma ‘s Chief Operating Officer. Orphan drug status provides accelerate the development accelerate the development of Polyphenon E as an oral treatment for patients with CLL. This in turn could lead to other potential development opportunities for this drug in oncology. .
Response of President Obama call for ‘a cure for cancer in our time ‘, which Pharmaceutical Research and Manufacturers of America supplied a new report now on medications in the development pipeline for cancer. The report displays that American drug research and biotechnology company test the record number of from 861 the new Krebs medicines and vaccines. The medicines are listed in the report which tested for into clinical trials in man or wait for approval by the U.S. Food and Drug Administration.